Skip to content
← Holders

KVP Capital Advisors, LP

What KVP Capital Advisors, LP reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1858198 · Filed Nov 16, 2026

Positions
36
Reported value
$124.3M
Opened
4
Closed
3
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Dec 31, 2025$103.3M
    27 positions
  2. Mar 31, 2026$133.9M
    32 positions
  3. Jun 30, 2026$136.2M
    35 positions
  4. Sep 30, 2026$124.3M
    36 positions
SecuritySharesChangeValueOf portfolio
PRAXPraxis Precision Medicines, Inc.
42.9K±0%$12.5M10.1%
WHWKWhitehawk Therapeutics, Inc.
2.2M±0%$8.1M6.6%
SLNSilence Therapeutics plc
684.1KNew$7.5M6%
PTGXProtagonist Therapeutics, Inc
53K±0%$7.5M6%
MBXMBX Biosciences, Inc.
121.5K±0%$7.1M5.7%
ERASErasca, Inc.
455K±0%$6.7M5.4%
TRVITrevi Therapeutics, Inc.
414K±0%$5.9M4.8%
TNGXTango Therapeutics, Inc.
230.3K±0%$5.7M4.6%
EWTXEdgewise Therapeutics, Inc.
133K±0%$5.4M4.3%
TNDMTandem Diabetes Care Inc
301K±0%$4.9M3.9%
ACHVAchieve Life Sciences, Inc.
462.4K±0%$3.7M3%
STROSutro Biopharma, Inc.
226.6K±0%$3.7M2.9%
INSMInsmed Inc
28.5K±0%$3.3M2.6%
SVRASavara Inc
605.3K±0%$3.1M2.5%
AVBPArriVent BioPharma, Inc.
102K±0%$3.1M2.5%
IDYAIDEAYA Biosciences, Inc.
79.7K±0%$3.1M2.5%
IRONDisc Medicine, Inc.
43.8K−24.9%$2.9M2.3%
UTHRUnited Therapeutics Corp
4.8K±0%$2.6M2.1%
VRDNViridian Therapeutics, Inc.
125K±0%$2.6M2.1%
IMMXImmix Biopharma, Inc.
230.4K±0%$2.4M1.9%
DSGNDesign Therapeutics, Inc.
185K±0%$2.3M1.9%
OCULOcular Therapeutix, Inc
300K±0%$2.3M1.9%
TVTXTravere Therapeutics, Inc.
39K±0%$2.3M1.8%
MLYSMineralys Therapeutics, Inc.
84.2K±0%$2.1M1.7%
VOGXVogenx, Inc.
86.1KNew$2M1.6%
NKTRNektar Therapeutics
26.9K±0%$1.6M1.3%
DRUGBright Minds Biosciences Inc.
31.8K±0%$1.6M1.3%
ZURAZura Bio Ltd
373.1K±0%$1.6M1.2%
ARTVArtiva Biotherapeutics, Inc.
200K±0%$1.4M1.1%
EOLSEvolus, Inc.
150K±0%$1.2M1%
VERAVera Therapeutics, Inc.
32.7K±0%$1.1M0.8%
CABACabaletta Bio, Inc.
505.4K±0%$970.4K0.8%
ADILAzora Therapeutics, Inc. (DE)
210.3KNew$843.1K0.7%
CMPXCompass Therapeutics, Inc.
771K±0%$801.8K0.6%
CELCCelcuity Inc.
4K±0%$318.1K0.3%
YARWYarrow Bioscience, Inc.
10KNew$225.4K0.2%